Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Use of Fluorescence in Gliomas
A clinical trial evaluating fluorescence-guided techniques in glioma surgery has completed, including participants with glioblastoma and oth…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma [Phase 1]
Phase 1 trial of hyperpolarized carbon-13 pyruvate imaging in glioblastoma patients has completed, evaluating this metabolic imaging approac…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 trial evaluating an autologous tumor lysate-loaded dendritic cell vaccine in patients with newly diagnosed glioblastoma has comp…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma [Phase 2]
Phase 2 clinical trial assessing pembrolizumab with standard therapy for glioblastoma and gliosarcoma; status update indicates ongoing or co…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 2]
Update on a Phase 2 trial evaluating multiparametric MRI-guided high-dose adaptive radiotherapy with concurrent temozolomide for newly diagn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma. [Phase 1]
This Phase 1 study is evaluating the safety and efficacy of TX103 CAR-T cell therapy in patients with recurrent or progressive Grade 4 gliom…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Glioma Modified Atkins-based Diet in Patients With Glioblastoma [NA]
A clinical trial examining a Modified Atkins diet for patients with glioblastoma has completed (status: COMPLETED).
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption [NA]
This completed study evaluated the safety and feasibility of ExAblate–mediated blood-brain barrier disruption in glioma and glioblastoma.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating Exablate Blood-Brain Barrier disruption for recurrent glioblastoma in patients receiving carboplatin …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients [Phase 2]
A Phase 2 clinical trial evaluating a hemp-derived cannabidiol product for anxiety in glioblastoma patients was terminated, and the results …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Testing Ramipril to Prevent Memory Loss in People With Glioblastoma [Phase 2]
A Phase 2 trial evaluating ramipril to prevent memory loss in glioblastoma patients undergoing radiotherapy has completed enrollment and pos…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms [Phase 2]
A Phase 2 clinical trial evaluating Fluoroethyltyrosine for the evaluation of intracranial neoplasms, including low-grade glioma and recurre…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma [Phase 1]
A Phase 1 study by UC Davis evaluated systemic and local lidocaine levels during glioblastoma surgery; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma [Phase 1]
Phase 1 clinical trial update for an IL-8 receptor-modified CD70 CAR T cell therapy in adults with glioblastoma. The study is currently acti…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma [EARLY_Phase 1]
Clinical trial update announcing an EARLY Phase 1 study of niraparib for newly diagnosed glioblastoma and recurrent glioma; the trial status…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients [EARLY_Phase 1]
Early-phase trial update reports completion of a Phase 1 study evaluating LY3214996 in combination with abemaciclib for recurrent glioblasto…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas
This clinical trial update reports a comprehensive analysis of chemotherapy and targeted therapy outcomes in recurrent malignant gliomas, in…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Effect of stRess and exeRcize on the Outcome After Chemo-Radiation
This clinical trial update reports the completion of a study assessing whether stress and exercise influence outcomes after chemo-radiation …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) [Phase 1]
A Phase 1 trial evaluating the safety of combining 5-ALA with the CV01 ultrasound delivery system for sonodynamic therapy in patients with n…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume [NA]
The document reports a clinical trial evaluating limiting the glioblastoma clinical target volume during radiotherapy to improve outcomes an…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma [Phase 1]
Phase 1 clinical trial update on combining capecitabine with bevacizumab in patients with recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of CVGBM in adults with newly diagnosed MGMT-unmethylated glioblastoma or astrocytoma…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the safety and potential activity of TN-TC11G (THC+CBD) in combination with temozolomide and radi…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Feasibility of Individualized Therapy for Recurrent Glioblastoma [Phase 1]
Phase 1 clinical trial assessing the feasibility of individualized therapy for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma [Phase 2]
Phase 2 study of MT027 allogeneic CAR-T for recurrent glioblastoma (IDH-wildtype) is not yet recruiting, per the trial update.